Skip to main content
OpenTrials

Clinical trial condition

Colorectal Cancer (CRC)

Explore clinical trials studying Colorectal Cancer (CRC). Study availability and eligibility vary by location and protocol.

97 public trials 49 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Cancer (CRC) trial results

Completed

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

NCT03314935

Conditions
Adnexal Diseases, Biliary Tract Cancer (BTC), Biliary Tract Diseases, +32 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • USA Mitchell Cancer Center Mobile, Alabama, United States
  • UC Davis - Comprehensive Cancer Centre Sacramento, California, United States
  • Northwest Georgia Oncology Centers Marietta, Georgia, United States
View Trial Details
Completed

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

NCT02903914

Conditions
Adenocarcinoma, Adenoma, Bladder Cancer, +49 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Honor Health/Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • Georgetown Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Completed

Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment

NCT04256707

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • Hadassah Ein Karem University Hospital Jerusalem, Israel
  • University Hospital Assuta Ashdod Ashdod, Israel
  • Soroka University Medical Center Beersheba, Israel
  • Oncology Department Hillel Yaffe Medical Center Hadera, Israel
View Trial Details
Completed

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

NCT02646748

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +59 more
Locations
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • John Wayne Cancer Institute at Providence Saint John's Health Center Santa Monica, California, United States
  • Georgetown University Medical Center Lombardi CCC Washington D.C., District of Columbia, United States
  • Hematology-Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
View all 17 locations
View Trial Details
Completed

Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer

NCT00851045

Conditions
Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +9 more
Locations
  • Acrc/Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
  • Compassionate Cancer Care Medical Group Inc Fountain Valley, California, United States
  • Compassionate Cancer Care Medical Group, Inc Riverside, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 15 locations
View Trial Details

Related conditions